BioSpace News Archive

Drug Development

Teva and Regeneron Announce Positive Topline Phase 3 Fasinumab Results in Patients with Chronic Pain from Osteoarthritis of the Knee or Hip

Data include final primary efficacy results and an interim safety analysis

August 16, 2018
·
15 min read
Stars Rally Together Again for Stand Up To Cancer’s Live Broadcast on September 7

2018 Telecast Marks Ten Years Of Making An Impact With Groundbreaking Cancer Research for Stand Up To Cancer

August 16, 2018
·
12 min read
FDA

Grifols Achieves Key Milestone with FDA Approval of the New Consolidated Manufacturing Facility (CMF) for Production of Recombinant Proteins

The new facility, equipment, and automation systems ensure reliable production of antigens for blood supply safety and patient health.

August 16, 2018
·
5 min read
Bone Index Ltd. Announces Medicare Reimbursement Coverage for Bindex Osteoporosis Measurement

Bone Index Ltd. announces that U.S. Centers for Medicare & Medicaid Services (CMS) has approved coverage for Bindex® measurement in the Ambulatory Surgical Center (ASC) setting

August 16, 2018
·
2 min read
Business

Anthem Blue Cross and Blue Shield Collaborates with Propeller Health to Support Consumers with COPD

Propeller Health’s digital medicines allow Anthem Blue Cross and Blue Shield consumers to better manage COPD symptoms

August 16, 2018
·
4 min read
Business

Evecxia Inc. Appoints John Kaiser as Chief Executive Officer

Evecxia, Inc. today announced that its Board of Directors has appointed John Kaiser as Chief Executive Officer (CEO) and interim Chairman of the Board. Mr. Kaiser has been working with the company’s management team and Board since March 2018.

August 16, 2018
·
2 min read
Pharm Country

Microbial Activity in the Mouth May Differentiate Children with Autism Spectrum Disorder

New research suggests that shifts in the bacteria within a child’s mouth could provide objective biomarkers for identifying autism spectrum disorder.

August 16, 2018
·
4 min read
Biotech Beach

Scientist.com Named One of America’s Ten Fastest-Growing Private Companies by Inc. Magazine

Pharmaceutical marketplace pioneer posts three-year revenue growth of 15,268%

August 16, 2018
·
2 min read
Biotech Bay

Eureka Therapeutics Announces Publication of Armored T-Cell Proof-of-Concept Study in Nature Biotechnology

This approach was developed in collaboration with Renier J. Brentjens, M.D., Ph.D., Director of the Cellular Therapeutics Center at Memorial Sloan Kettering Cancer Center

August 16, 2018
·
4 min read
Business

Aeromics, Inc. Appoints Pharmaceutical and Biotech Veterans Mark Day, Ph.D. and Thomas Zindrick, J.D. to Its Board of Directors

Dr. Day is renowned for his neuroscience and business development accomplishments and Mr. Zindrick is prominently recognized for his legal and corporate governance experience

August 16, 2018
·
7 min read